Article Versions Notes

Takahara H, Kanazawa T, Oshita H, Tomita Y, Hananoi Y, Ishibashi S, Ikeda M, Furukawa A, Kinoshita M, Yamamoto K, et al. GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies. Cancers. 2024; 16(22):3888. https://doi.org/10.3390/cancers16223888

Takahara, Hirotomo, Takumi Kanazawa, Haruna Oshita, Yoshinobu Tomita, Yuri Hananoi, Sachiko Ishibashi, Masumi Ikeda, Asuka Furukawa, Mayumi Kinoshita, Kurara Yamamoto, and et al. 2024. "GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies" Cancers 16, no. 22: 3888. https://doi.org/10.3390/cancers16223888

Takahara, H., Kanazawa, T., Oshita, H., Tomita, Y., Hananoi, Y., Ishibashi, S., Ikeda, M., Furukawa, A., Kinoshita, M., Yamamoto, K., Kato, Y., Ishibashi, H., Okubo, K., Kurata, M., Kitagawa, M., Ohashi, K., & Yamamoto, K. (2024). GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies. Cancers, 16(22), 3888. https://doi.org/10.3390/cancers16223888